IceCure Medical (ICCM) Shares Outstanding (Diluted Average) (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $73.6 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 27.64% year-over-year to $73.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.6 million (up 27.64% YoY) and the FY2025 annual result came in at $63.6 million, up 24.97% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $73.6 million in Q1 2026 per ICCM's latest filing, from $63.6 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $73.6 million in Q1 2026 and bottomed at $37.0 million in Q4 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $54.3 million (2024), against an average of $54.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) rose 29.66%; it then advanced 11.48% in 2024.
• Tracing ICCM's Shares Outstanding (Diluted Average) over 5 years: stood at $37.0 million in 2022, then grew by 23.29% to $45.6 million in 2023, then advanced by 11.48% to $50.9 million in 2024, then climbed by 24.97% to $63.6 million in 2025, then climbed by 15.72% to $73.6 million in 2026.
• Per Business Quant, the three latest ICCM Shares Outstanding (Diluted Average) figures stand at $73.6 million (Q1 2026), $63.6 million (Q4 2025), and $57.6 million (Q1 2025).

Peer Comparison